Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
ASTH
Strong BuyFLAGAstrana Health, Inc. · Healthcare · United States · $1.9B · Avg Vol: $19M/d
Astrana Health has exceptional momentum at M88 with a buyback on file, but quality at Q46 and value at V48 are both below the calibrated floor, so stage one fails.
COMPANY DESCRIPTION
Astrana Health, Inc. (formerly Apollo Medical Holdings) is an integrated healthcare delivery and technology company that provides value-based care management services, primarily to Medicare Advantage members. Its competitive moat is built on a physician-centric, integrated care model that leverages proprietary technology and data analytics to improve patient outcomes and reduce costs for complex populations. Astrana Health is a leading innovator in value-based care, focused on risk-bearing contracts and delivering comprehensive, coordinated care.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 1.1B | 1.4B | 2.0B | 3.2B | 40.6% | 3.8B | 4.0B | 4.4B | 17.4% |
| EPS | — | 1.09 | 1.30 | 0.91 | 0.46 | -25.0% | 0.82 | 0.66 | 0.77 | 29.1% |
| Shares | — | 46.6M | 46.8M | 47.9M | 48.9M | +5.0% | 49.6M | — | — | — |
| Debt | — | 229.4M | 321.0M | 470.7M | 1.1B | 67.5% | 979.4M | — | — | — |
| Equity | 448.2M | 542.6M | 410.8M | 514.2M | 558.3M | 5.6% | — | — | — | — |
| Op CF | — | 82.1M | 68.2M | 52.2M | 114.6M | 11.7% | 107.9M | — | — | — |
| Inv CF | — | -7.1M | -65.5M | -192.4M | -539.0M | — | — | — | — | — |
| Fin CF | — | -20.1M | 3.4M | 135.1M | 569.3M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ASTH are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| ASTH | Astrana Health, Inc.(you) | $1.9B | 84 | Strong Buy |
| ARDT | Ardent Health, Inc. | $1.6B | 86 | Strong Buy |
| GRDN | Guardian Pharmacy Services, Inc. | $2.4B | 87 | Strong Buy |
| ADUS | Addus HomeCare Corporation | $2.3B | 92 | Strong Buy |
| HCSG | Healthcare Services Group, Inc. | $1.6B | 95 | Strong Buy |
| MD | Pediatrix Medical Group, Inc. | $2.2B | 98 | Strong Buy |
| AMN | AMN Healthcare Services, Inc. | $1.3B | 96 | Strong Buy |
| NHC | National HealthCare Corporation | $3.6B | 91 | Strong Buy |
| AVAH | Aveanna Healthcare Holdings Inc. | $3.0B | 95 | Strong Buy |
| LFST | LifeStance Health Group, Inc. | $4.6B | 81 | Strong Buy |
Peer medians: ROE -25.8% · P/E 29.5x · Gross margin 58.8%